Second Opinion: What the pandemic taught us about global and national public health
In this episode, we look at the troubled public health responses to the COVID-19 pandemic around the world and here in the United States. We also examine what the pandemic taught us about how we might handle lesser-known diseases affecting the world’s poorest people. Our guests are Peter Hotez, a virologist at Baylor College of Medicine, and Elisabeth Rosenthal, the editor-in-chief of Kaiser Health News.
Second Opinion is produced by L.A. Times Studios in conjunction with the L.A. Times newsroom. Its host is Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times. This episode is moderated by Times White House reporter Eli Stokols.
Dr. Patrick Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious disease. Last year, Soon-Shiong’s company, ImmunityBio, received permission from the Food and Drug Administration to begin Phase 1 trials of its COVID-19 vaccine candidate. He has also received approval to begin trials in South Africa, where he will explore the potential of his T cell vaccine to prevent infection from mutated strains of the coronavirus.
Second Opinion is produced by L.A. Times Studios in conjunction with the L.A. Times newsroom. Its host is Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times. This episode is moderated by Times White House reporter Eli Stokols.
Dr. Patrick Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious disease. Last year, Soon-Shiong’s company, ImmunityBio, received permission from the Food and Drug Administration to begin Phase 1 trials of its COVID-19 vaccine candidate. He has also received approval to begin trials in South Africa, where he will explore the potential of his T cell vaccine to prevent infection from mutated strains of the coronavirus.